ICAM1 and dry eye syndrome: This is in agreement with previous studies in symptomatic, moderate dry eye patients, where there were no increases in levels of IL-1β, IL-6, IL-8/CXCL8, GRO-b, ICAM-1, TRAIL, or ephrin A5 in tear fluid [36].